About Sunitinib Sunitinib is an anti-cancer medication. It is a small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved…
TYVYT® (sintilimab injection) is a fully human IgG4 monoclonal antibody, which specifically binds to PD-1 expressed on…
About Toripalimab Toripalimab-tpzi is a next generation anti-PD-1 monoclonal antibody that blocks PD-L1 binding to the…
About Cejemly® (Sugemalimab) The anti-PD-L1 monoclonal antibody sugemalimab was discovered by CStone using the OmniRat® transgenic animal…
HANQUYOU® (Trastuzumab) sold under the brand name 汉曲优® in china, Since its launch, 汉曲优® has been…
Larotrectinib Larotrectinib is a medication for the treatment of cancer.It is an inhibitor of tropomyosin kinase receptors TrkA, TrkB, and TrkC. …
Larotrectinib Larotrectinib is a medication for the treatment of cancer.It is an inhibitor of tropomyosin kinase receptors TrkA, TrkB, and TrkC. …
Tevimbra (Tislelizumab-jsgr) sold under the brand name 百泽安 in china, is a humanized IgG4 anti–PD-1 monoclonal…
Zerpidio (Serplulimab) sold under the brand name 汉斯状 in china. Serplulimab, a recombinant humanised anti-PD-1 monoclonal…
Larotrectinib is a treatment for solid cancers that have a neurotrophic tyrosine receptor kinase (NTRK) gene change.…
Larotrectinib is a treatment for solid cancers that have a neurotrophic tyrosine receptor kinase (NTRK) gene change.…
Copyright © 2021-2022 LienTeh.net All rights reserved.
